Is pancreatitis a complication of endoscopic ultrasound guided fine needle aspiration of the pancreas?

F. Gress, S. Ikenberry, D. Ciaccia, J. Kiel, Glen Lehman

Research output: Contribution to journalArticle

Abstract

Introduction: Endoscopic ultrasound (EUS) guided fine needle aspiration (FNA) of the pancreas is increasingly being utilized to diagnose pancreatic masses. We have previously reported 2 cases of clinical pancreatitis following EUS guided FNA of the pancreas. Aim of Study: To determine the frequency of chemical and clinical pancreatitis following EUS guided FNA of the pancreas. Methods: All patients having EUS guided FNA biopsy of the pancreas were eligible. Exclusion criteria included: All patients with acute pancreatitis or having ERCP within 48 hours of the EUS FNA. Serum amylase and lipase levels were measured immediately prior to and 2 hours post EUS FNA. Patients were called 24-72 hours after FNA to follow up for increased pain, nausea, or vomiting suggesting clinical pancreatitis. Results: Data was prospectively collected on 36 patients. Pre- and post-FNA amylase and lipase levels were available for all patients. Ten patients had a past history of pancreatitis prior to the EUS FNA. Pre and Post EUS Guided FNA Serum Enzyme Levels Mean Pre Mean Post Mean Change CI P Value Amylase 70.0 75.0 5.0 -31.4, 20.2 .47 Lipase 315.0 547.6 232.0 -458.9, -6.05 .044 CI = Confidence Interval As a group, there was a mean increase in serum amylase and lipase levels. When matched pair analysis was performed, the differences were not statistically significant for amylase levels but were for lipase (p<0,05) suggesting that lipase may be a more sensitive marker. There were no episodes of clinical pancreatitis. The lipase levels were elevated the most in 60% (6/10) of patients with a past history of pancreatitis. Conclusion: This prospective study found no evidence of clinical pancreatitis. Patients with a prior history of pancreatitis had higher amylase and lipase levels than those who did not suggesting this as a possible risk factor. Based on this prospective study, further investigations are warranted to evaluate the true risk of pancreatitis from this procedure.

Original languageEnglish
JournalGastrointestinal Endoscopy
Volume45
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Endoscopic Ultrasound-Guided Fine Needle Aspiration
Pancreatitis
Pancreas
Lipase
Amylases
Fine Needle Biopsy
Serum
Prospective Studies
Matched-Pair Analysis
Endoscopic Retrograde Cholangiopancreatography
Nausea
Vomiting

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Is pancreatitis a complication of endoscopic ultrasound guided fine needle aspiration of the pancreas? / Gress, F.; Ikenberry, S.; Ciaccia, D.; Kiel, J.; Lehman, Glen.

In: Gastrointestinal Endoscopy, Vol. 45, No. 4, 1997.

Research output: Contribution to journalArticle

@article{a142b88bf0f6449bae70294936b42b32,
title = "Is pancreatitis a complication of endoscopic ultrasound guided fine needle aspiration of the pancreas?",
abstract = "Introduction: Endoscopic ultrasound (EUS) guided fine needle aspiration (FNA) of the pancreas is increasingly being utilized to diagnose pancreatic masses. We have previously reported 2 cases of clinical pancreatitis following EUS guided FNA of the pancreas. Aim of Study: To determine the frequency of chemical and clinical pancreatitis following EUS guided FNA of the pancreas. Methods: All patients having EUS guided FNA biopsy of the pancreas were eligible. Exclusion criteria included: All patients with acute pancreatitis or having ERCP within 48 hours of the EUS FNA. Serum amylase and lipase levels were measured immediately prior to and 2 hours post EUS FNA. Patients were called 24-72 hours after FNA to follow up for increased pain, nausea, or vomiting suggesting clinical pancreatitis. Results: Data was prospectively collected on 36 patients. Pre- and post-FNA amylase and lipase levels were available for all patients. Ten patients had a past history of pancreatitis prior to the EUS FNA. Pre and Post EUS Guided FNA Serum Enzyme Levels Mean Pre Mean Post Mean Change CI P Value Amylase 70.0 75.0 5.0 -31.4, 20.2 .47 Lipase 315.0 547.6 232.0 -458.9, -6.05 .044 CI = Confidence Interval As a group, there was a mean increase in serum amylase and lipase levels. When matched pair analysis was performed, the differences were not statistically significant for amylase levels but were for lipase (p<0,05) suggesting that lipase may be a more sensitive marker. There were no episodes of clinical pancreatitis. The lipase levels were elevated the most in 60{\%} (6/10) of patients with a past history of pancreatitis. Conclusion: This prospective study found no evidence of clinical pancreatitis. Patients with a prior history of pancreatitis had higher amylase and lipase levels than those who did not suggesting this as a possible risk factor. Based on this prospective study, further investigations are warranted to evaluate the true risk of pancreatitis from this procedure.",
author = "F. Gress and S. Ikenberry and D. Ciaccia and J. Kiel and Glen Lehman",
year = "1997",
language = "English",
volume = "45",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Is pancreatitis a complication of endoscopic ultrasound guided fine needle aspiration of the pancreas?

AU - Gress, F.

AU - Ikenberry, S.

AU - Ciaccia, D.

AU - Kiel, J.

AU - Lehman, Glen

PY - 1997

Y1 - 1997

N2 - Introduction: Endoscopic ultrasound (EUS) guided fine needle aspiration (FNA) of the pancreas is increasingly being utilized to diagnose pancreatic masses. We have previously reported 2 cases of clinical pancreatitis following EUS guided FNA of the pancreas. Aim of Study: To determine the frequency of chemical and clinical pancreatitis following EUS guided FNA of the pancreas. Methods: All patients having EUS guided FNA biopsy of the pancreas were eligible. Exclusion criteria included: All patients with acute pancreatitis or having ERCP within 48 hours of the EUS FNA. Serum amylase and lipase levels were measured immediately prior to and 2 hours post EUS FNA. Patients were called 24-72 hours after FNA to follow up for increased pain, nausea, or vomiting suggesting clinical pancreatitis. Results: Data was prospectively collected on 36 patients. Pre- and post-FNA amylase and lipase levels were available for all patients. Ten patients had a past history of pancreatitis prior to the EUS FNA. Pre and Post EUS Guided FNA Serum Enzyme Levels Mean Pre Mean Post Mean Change CI P Value Amylase 70.0 75.0 5.0 -31.4, 20.2 .47 Lipase 315.0 547.6 232.0 -458.9, -6.05 .044 CI = Confidence Interval As a group, there was a mean increase in serum amylase and lipase levels. When matched pair analysis was performed, the differences were not statistically significant for amylase levels but were for lipase (p<0,05) suggesting that lipase may be a more sensitive marker. There were no episodes of clinical pancreatitis. The lipase levels were elevated the most in 60% (6/10) of patients with a past history of pancreatitis. Conclusion: This prospective study found no evidence of clinical pancreatitis. Patients with a prior history of pancreatitis had higher amylase and lipase levels than those who did not suggesting this as a possible risk factor. Based on this prospective study, further investigations are warranted to evaluate the true risk of pancreatitis from this procedure.

AB - Introduction: Endoscopic ultrasound (EUS) guided fine needle aspiration (FNA) of the pancreas is increasingly being utilized to diagnose pancreatic masses. We have previously reported 2 cases of clinical pancreatitis following EUS guided FNA of the pancreas. Aim of Study: To determine the frequency of chemical and clinical pancreatitis following EUS guided FNA of the pancreas. Methods: All patients having EUS guided FNA biopsy of the pancreas were eligible. Exclusion criteria included: All patients with acute pancreatitis or having ERCP within 48 hours of the EUS FNA. Serum amylase and lipase levels were measured immediately prior to and 2 hours post EUS FNA. Patients were called 24-72 hours after FNA to follow up for increased pain, nausea, or vomiting suggesting clinical pancreatitis. Results: Data was prospectively collected on 36 patients. Pre- and post-FNA amylase and lipase levels were available for all patients. Ten patients had a past history of pancreatitis prior to the EUS FNA. Pre and Post EUS Guided FNA Serum Enzyme Levels Mean Pre Mean Post Mean Change CI P Value Amylase 70.0 75.0 5.0 -31.4, 20.2 .47 Lipase 315.0 547.6 232.0 -458.9, -6.05 .044 CI = Confidence Interval As a group, there was a mean increase in serum amylase and lipase levels. When matched pair analysis was performed, the differences were not statistically significant for amylase levels but were for lipase (p<0,05) suggesting that lipase may be a more sensitive marker. There were no episodes of clinical pancreatitis. The lipase levels were elevated the most in 60% (6/10) of patients with a past history of pancreatitis. Conclusion: This prospective study found no evidence of clinical pancreatitis. Patients with a prior history of pancreatitis had higher amylase and lipase levels than those who did not suggesting this as a possible risk factor. Based on this prospective study, further investigations are warranted to evaluate the true risk of pancreatitis from this procedure.

UR - http://www.scopus.com/inward/record.url?scp=33748963471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748963471&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748963471

VL - 45

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 4

ER -